FDA Panel: Vaccine Protects Against a Cancer
An FDA panel recommends the approval of a vaccine to prevent cervical cancer, the second-most deadly cancer for women. The new vaccine, made by Merck, could reduce the number of cervical cancer cases world wide by about two-thirds.
The vaccine protects against the most carcinogenic forms of the human papilloma virus, or HPV, which causes cervical cancer. The federal review panel was unanimous in its approval of the vaccine.
Comments
Discussions for this story are now closed. Please see the Community FAQ for more information.